Cited by 4Bipolar Disorder and TreatmentSchizophrenia research and treatmentCardiac Health and Mental Health

The risk of developing cardiovascular disease in bipolar disorder. Biological factors and therapy

Open access
Mosolov, Sergey N., Fedorova, Elizaveta Yu.·2022·Terapevticheskii arkhiv

Abstract

BACKGROUND: Bipolar disorder (BD) is one of the most common mental disorders characterized by alternating episodes of mania/hypomania and depression, as well as the possibility of developing mixed conditions. Correct and timely diagnosis of BD is important due to the presence of a high suicidal risk and a high predisposition to the development of cardiovascular disease (CVD). The risk of CVD is higher in ВD than in other mental disorders. MATERIALS AND METHODS: A sample assessment was made of current studies focusing on the vascular-bipolar link. The search was carried out in the PubMed and eLIBRARY databases for the following keywords: bipolar disorder, psychopharmacology, cardiovascular disease, biological mediators. RESULTS: There are several biological factors which explain the close association and common pathogenetic mechanisms of BD and CVD. The most interesting of them are inflammation, oxidative stress, and brain-derived neurotrophic factor. Neuroimaging methods have shown similar structural brain changes in people with BD and with CVD. There is some evidence of the efficacy of statins and angiotensin-converting enzyme inhibitors in reducing cardio-vascular risk factors in BD patients. CONCLUSION: The predisposition of patients of BD to CVD is beyond doubt. It is necessary to consider the peculiarities of the course of BD and conduct active monitoring and preventive measures to reduce the risk of developing life-threatening CVDs. Further research focused on the pathogenetic relationship between BD and CVD could provide more insight into this area.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.26442/00403660.2022.04.201455

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Smoking is the most relevant biological mediator of comorbid cardiovascular disease in people with bipolar disorder.

    “This mechanism also makes smoking the most relevant biological mediator of co-morbid cardiovascular disease in people with BD (38).”

    From The detrimental effects of smoking on the course and outcome in adults with bipolar disorder—A narrative review (2023) · cites this paper as [38]

    The section on inflammation, oxidative stress and BDNF (p. 580–581) discusses biological links between bipolar disorder and cardiovascular disease, but does not identify smoking as a mediator or rank it above other factors. Searches for курение (smoking), tobacco and nicotine found no passage in our copy addressing that claim. (LLM, conf=0.75)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 7

  1. TERAPEVTICHESKIIARKHIV.2022;94(4):579-583. ТЕРАПЕВТИЧЕСКИЙАРХИВ.2022;94(4):579-583. ЛИТЕРАТУРА/REFERENCES
  2. Angst J, Adolfsson R, Benazzi F, et al. The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients. J Affect Disord. 2005;88:217-33. DOI:10.1016/j.jad.2005.05.0111. · DOI
  3. Мосолов С.Н., Федорова Е.Ю. Риск развития сердечно-сосудистых забо- леваний при биполярном расстройстве. Клинико-социальные факторы. Терапевтический архив. 2021;93(12):1556-61 [
  4. Петрова Н.Н., Майорова М.А. Роль кинуренинового пути в развитии и терапии депрессии. Современная терапия психических расстройств. 2018;4:2-7 [
  5. АВП -антипсихотики II поколения БР -биполярное расстройство ДИ -доверительный интервал ИАПФ -ингибиторы ангиотензинпревращающего фермента ИЛ -интерлейкин ИМТ -индекс массы тела МРТ -магнитно-резонансная томография ОШ -отношение шансов РДР -рекуррентное депрессивное расстройство РКИ -рандомизированное клиническое исследование СРС -стандартизованное различие средних при 95% доверительном интервале ССЗ -сердечно-сосудистые заболевания ССФР -сердечно-сосудистые факторы риска ЦК -церебральный кровоток BDNF -нейротрофический фактор головного мозга ES -размер эффекта Список сокращений https://doi.org/10.26442/00403660.2022.04.201455 REVIEW ТЕРАПЕВТИЧЕСКИЙАРХИВ.2022;94(4):579-583. TERAPEVTICHESKIIARKHIV.2022;94(4):579-583. 583 · DOI
  6. Мосолов С.Н. Сравнительная эффективность профилактического применения карбоната лития, карбамазепина, вальпроата натрия при аффективных и шизоаффективных психозах. Журнал неврологии и психиатрии им. С.С. Корсакова. 1991;4:78-83 [Mosolov SN. Comparative efficacy of preventive use of lithium carbonate, carbamazepine and sodium valproate in affective and schizoaffective psychoses. S.S. Korsakov Journal of Neurology and Psychiatry. 1991;4:78-83 (in Russian)].
  7. Алфимов П.В., Рывкин П.В., Ладыженский М.Я., и др. Метаболический синдром у больных шизофренией (обзор литературы). Современная терапия психических расстройств. 2014;3:8-14 [Alfimov PV, Ryvkin PV, Ladyzhensky MY, et al. Metabolic syndrome in patients with schizophrenia (a review). Current Therapy of Mental Disorders. 2014;3:8-14 (in Russian)].

Cited by

Sorted by citations

Authors
Mosolov, S. N., & Fedorova, E. Y.
Affiliations
  • Russian Medical Academy of Continuous Professional Education (RU)
  • Federal Medical Research Centre for Psychiatry and Narcology (RU)
Venue
Terapevticheskii arkhiv
Published
2022-05-26
Volume
94
Issue
4
Pages
579-583
ISSN
  • 0040-3660 (ISSN-L)
  • 2309-5342
OpenAlex
W4281554349
Cited by
4
References
48
Citations by year
2024: 2 · 2023: 2
FWCI
0.65
Type
journal article
Language
ru
Open access
Locations
  • Terapevticheskii arkhiv (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Keywords
bipolar disorder, cardiovascular disease, inflammation, oxidative stress, brain-derived neurotrophic factor, neuroimaging, statins, ACE inhibitors, cardiovascular risk factors, psychopharmacology
MeSH terms
Angiotensin-Converting Enzyme Inhibitors, Biological Factors, Bipolar Disorder, Cardiovascular Diseases, Humans, Risk Factors, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Brain-Derived Neurotrophic Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review